MicroRNAs as Biomarkers for Obstructive Sleep Apnea
NCT: NCT06189755 · RECRUITING
Brief Summary
Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.
Frequently Asked Questions
What is MicroRNAs as Biomarkers for Obstructive Sleep Apnea?
MicroRNAs as Biomarkers for Obstructive Sleep Apnea is a clinical trial registered under NCT06189755. Current status: RECRUITING.
What is the status of NCT06189755?
The current status of NCT06189755 (MicroRNAs as Biomarkers for Obstructive Sleep Apnea) is: RECRUITING.
When did MicroRNAs as Biomarkers for Obstructive Sleep Apnea start?
MicroRNAs as Biomarkers for Obstructive Sleep Apnea started on 2024-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.